Table 2:

Distribution of incident first primary cancers diagnosed among people with and without HIV infection

Cancer groupNo. (%) of people*Standardized difference
With HIV infectionWithout HIV infectionTotsal
All cancers1534 (100.0)903 (100.0)2437 (100.0)–
Infection-unrelated cancer696 (45.4)784 (86.8)1480 (60.7)0.97
Infection-related cancer838 (54.6)119 (13.2)957 (39.3)0.97
 ADC559 (36.4)45 (5.0)604 (24.8)0.84
 Non-Hodgkin lymphoma305 (19.9)37 (4.1)342 (14.0)0.50
 Kaposi sarcoma†235–241< 6241 (9.9)0.58
 Cervix†15–21< 621 (0.9)0.08
 Infection-related NADC279 (18.2)74 (8.2)353 (14.5)0.30
 Most common site-specific NADCs among people with HIV infection
  Prostate116 (7.6)186 (20.6)302 (12.4)0.38
  Lung121 (7.9)98 (10.8)219 (9.0)0.10
  Colorectal80 (5.2)106 (11.7)186 (7.6)0.24
  Anal†106–112 (6.9–7.3)< 6112 (4.6)0.36
  Liver49 (3.2)19 (2.1)68 (2.8)0.07

  • Note: ADC = AIDS-defining cancer, NADC = non–AIDS defining cancer.

  • ↵* Column proportions do not sum to 100% as cancers could be in more than 1 category.

  • ↵† Ranges are shown to suppress small cell counts to prevent the risk of disclosure; cells with fewer than 5 cases were suppressed.